SCHEMBL17672370

SCHEMBL17672370

CON(C)C(=O)C1CCN(C(C)(C)C)C1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ USP30 Q70CQ3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3964578 0.91 BCHE (0.36) ATM
SCHEMBL15448158 0.90 SMN1; SMN2 (0.35) ATMSMN1; SMN2
SCHEMBL3709106 0.86 ATM (0.42) ATM
SCHEMBL29965898 0.84 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL10205037 0.83 BCHE (0.41) ATMSMN1; SMN2
SCHEMBL13212937 0.83 BCHE (0.41) ATMSMN1; SMN2
SCHEMBL13212938 0.83 BCHE (0.41) ATMSMN1; SMN2
SCHEMBL2655941 0.80 PDK2 (0.36) ATM
SCHEMBL413771 0.78 PKM (0.38) SMN1; SMN2
SCHEMBL20244607 0.77 BCHE (0.48) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3843728-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN Morphic Therapeutic, Inc. (US) 2021-07-07 — — EP disclosed
EP-3843727-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN Morphic Therapeutic, Inc. (US) 2021-07-07 — — EP disclosed
WO-2020047207-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN MORPHIC THERAPEUTICS, INC. (US) 2020-03-05 — — WO disclosed
WO-2020047208-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2020-03-05 — — WO disclosed
EP-3204379-A1 PYRROLIDINE AMIDE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS Genentech, Inc. (US) 2017-08-16 — — EP disclosed
WO-2016057924-A1 PYRROLIDINE AMIDE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS GENENTECH, INC. (US) 2016-04-14 — — WO disclosed
Send feedback